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A B S T R A C T
Background: The current decline observed in mortality rate among patients with ST-segment elevation 
acute myocardial infarction can be attributed not only to the increased use of reperfusion strategies, but 
also to a change in the demographic profile of this population, notably the reduction in mean age. 
Methods: We retrospectively reviewed all patients undergoing primary percutaneous coronary intervention 
in the period from April 2010 to December 2014. The primary objective was the characterization of the 
most prevalent risk factors, the angiographic nature of the lesions, the technical aspects of the procedure, 
and in-hospital clinical outcomes in patients aged ≤ 45 years, comparing them to those aged > 45 years. 
Results: Among 489 patients with acute myocardial infarction, 54 were ≤ 45 years, and 435 were > 45 
years. Young patients exhibited a higher prevalence of smoking and obesity, while patients > 45 years were 
more likely to have hypertension, diabetes mellitus, dyslipidemia, and previous myocardial infarction. 
Primary percutaneous coronary intervention in young patients was associated with the use of fewer guide 
catheters, shorter fluoroscopy time, and higher percentage of direct stent implantation. Young patients 
exhibited good in-hospital outcomes, with lower rate of adverse cardiac events (3.7% vs. 9.2%; p = 0.30). 
Conclusions: Patients aged ≤ 45 years accounted for approximately 10% of cases of ST-segment elevation 
acute myocardial infarction and exhibited high prevalence of modifiable risk factors.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Published by Elsevier Editora Ltda. 
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 
 
Perfil clínico e angiográfico de pacientes jovens submetidos à intervenção 
coronária percutânea primária
R E S U M O
Introdução: O atual declínio observado na taxa de mortalidade entre pacientes com infarto do miocárdio 
com supradesnivelamento do segmento ST pode ser atribuído não apenas a maior utilização de estratégias 
de reperfusão, mas também a uma mudança no perfil demográfico dessa população, notadamente à 
redução em sua média de idade.
Métodos: Foram analisados retrospectivamente todos os pacientes submetidos à intervenção coronária 
percutânea primária no período de abril de 2010 a dezembro de 2014. O objetivo primário foi a 
caracterização dos fatores de risco mais prevalentes, a natureza angiográfica das lesões, os aspectos 
técnicos do procedimento e a evolução clínica hospitalar de pacientes jovens, com idade ≤ 45 anos, 
comparando-os àqueles com idade > 45 anos. 
Resultados: Dentre 489 pacientes com diagnóstico de infarto agudo do miocárdio, 54 tinham idade ≤ 
45 anos e 435, idade > 45 anos. Pacientes jovens exibiram maior prevalência de tabagismo e obesidade, 
enquanto pacientes > 45 anos eram mais propensos a apresentar hipertensão arterial sistêmica, diabetes 
melito, dislipidemia e infarto do miocárdio antigo. Intervenção coronária percutânea primária em 
jovens associou-se ao uso de menor quantidade de cateteres-guia, menor tempo de fluoroscopia e maior 
porcentual de implante direto de stent. Pacientes jovens exibiram boa evolução hospitalar, com reduzida 
taxa de eventos cardíacos adversos (3,7% vs. 9,2%; p = 0,30).
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Conclusões: Pacientes com idade ≤ 45 anos representaram aproximadamente 10% dos casos de infarto 
agudo do miocárdio com supradesnivelamento do segmento ST e exibiram elevada prevalência de fatores 
de risco modificáveis.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Publicado por Elsevier Editora Ltda. 
Este é um artigo Open Access sob a licença de CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Data from the National Institutes of Health and from USA govern-
ment agencies indicate that coronary artery  disease was responsib-
le for one in seven deaths in that country in 2011.1 It is estimated 
that, each year, 635,000 Americans are hospitalized for acute coro-
nary syndrome. Although the mortality rate for ST-segment eleva-
tion acute myocardial infarction (STEMI) has decreased significantly 
- from 11.5%, in 1990, to 8.0%, in 2006-, this decrease can be attribu-
ted not only to advances in clinical pharmacotherapy and in reperfu-
sion strategies, notably primary percutaneous coronary intervention 
(PCI), but also to changes in the demographic profile of patients.
Among these changes, the decline in the mean age of patients af-
fected by STEMI stands out. A review of four French registries invol-
ving 6,707 people indicated a mean decrease from 66.2 to 63.3 years 
over the course of 15 years.2 In Brazil, the National Registry of Car-
diovascular Interventions (Central Nacional de Intervenções Cardio-
vasculares - CENIC), encompassing 20,004 procedures in a 5-year 
period (2006-2010), recorded a mean age of 60.8 years among pa-
tients with STEMI.3
The in-hospital and late outcomes of young patients with stable 
coronary artery disease in our country were recently characterized, 
attesting to a good long-term prognosis.4,5 However, clinical and an-
giographic information about this population in the acute phase of 
STEMI are scarce. Thus, the aim of this study was to obtain more in-
formation on this subject.
Methods
Study population
All patients diagnosed with STEMI undergoing primary PCI in a 
single center performing a large volume of procedures (> 70 primary 
PCIs/year) were analyzed retrospectively. Patients aged ≤ 45 years 
were classified as young patients, based on previous publications on 
the subject.6-8 
The primary aim of this study was the characterization of the 
most prevalent risk factors in young patients with STEMI, angiogra-
phic nature of lesions, technical details of primary PCI, and in-hospi-
tal clinical evolution, with emphasis on mortality rate, reinfarction, 
stroke, stent thrombosis, and the occurrence of major bleeding, 
comparing them to patients aged > 45 years.
Procedures
A 12-lead electrocardiogram, plus V3R, V4R, V7, and V8 leads in in-
ferior infarction, were performed at hospital admission and 30-60 
minutes after the procedure. Therapeutic interventions followed re-
commendations and practices established by the existing guide-
lines.9,10 Anticoagulation was obtained with unfractionated heparin 
(UFH) 100 U/kg IV and dual antiplatelet therapy with a loading dose 
of 300 mg of acetylsalicylic acid, plus clopidogrel 600 mg or ticagre-
lor 180 mg. The radial approach was the first choice of vascular ac-
cess. Manual thrombus aspiration and use of glycoprotein IIb/IIIa 
inhibitors were at the discretion of the operator. Dosages of creatine 
kinase MB isoenzyme (CK-MB) were performed every 6 hours, until 
a decrease in the level of this marker was observed.
Definitions
The following risk factors were assessed: smoking - active 
smoker, or abstinence from smoking occurring in less than 6 mon-
ths; hypercholesterolemia (low density lipoprotein-cholesterol - 
LDL-C > 160 mg/dL); systemic arterial hypertension (systolic blood 
pressure > 140 mmHg and/or diastolic blood pressure > 90 mmHg); 
diabetes mellitus (two fasting plasma glucose levels > 125 mg/dL on 
different days); family history of heart disease (atherosclerosis diag-
nosed in parents or siblings < 55 years for men and < 65 for women); 
prior manifestation of atherosclerotic disease (previous myocardial in-
farction, percutaneous or surgical revascularization procedure, stroke); 
and chronic renal failure (glomerular filtration rate < 60 mL/min or 
serum creatinine > 1.5 mg/dL). 
Regarding electrocardiographic location, acute myocardial 
infarction was classified as an anterior (anteroseptal, anterior, 
anterolateral, and extensive anterior) or inferior (inferior, late-
ral, and dorsal) event. Door-to-balloon time was defined as the 
interval between hospital admission and crossing of the lesion 
with a predilation balloon, manual thrombus aspiration cathe-
ter, or stent. Angiographic success was defined as a PCI with re-
duction of target stenosis to < 20% diameter, maintaining or 
restoring normal antegrade f low (Thrombolysis in Myocardial 
Infarction - TIMI grade 3). Major bleeding was defined as a Type 
3 or 5 bleeding according to the definition of the Bleeding Aca-
demic Research Consortium: type 3 – (3a) bleeding with hemo-
globin decrease ≥ 3 and < 5 g/dL or with red blood cell transfusion; 
(3b) bleeding with hemoglobin decrease ≥ 5 g/dL , or cardiac 
tamponade, or bleeding requiring surgical intervention, or blee-
ding requiring the use of intravenous vasoactive drugs; (3c) in-
tracranial hemorrhage, or subcategories confirmed by autopsy, 
imaging studies, or lumbar puncture, or intraocular bleeding 
with vision impairment; Type 5 – (5a) likely fatal bleeding; (5b) 
final fatal bleeding.11
Statistical analysis 
Qualitative variables were summarized in absolute frequencies 
and percentages, and quantitative data were expressed as mean ± 
standard deviation. To compare groups, the Chi-squared test or 
Fisher’s exact test for qualitative variables and Student’s t-test or the 
Mann-Whitney test for quantitative variables were used. Results 
with p < 0.05 were considered statistically significant.
Results
From April 2010 to December 2014, 2,674 PCIs were carried 
out; of these, 489 (18.3%) occurred in patients with STEMI in the 
first 12 hours of sympton onset. Of these patients, 54 (11%) were 
aged ≤ 45 years (mean 40.7 years, range 36-45 years), and 435 
were aged > 45 years (mean 64.2 years, range 46-96 years).
 P. de Andrade et al. / Rev Bras Cardiol Invasiva. 2015;23(2):91-95 93
Young patients exhibited a higher prevalence of smoking (72.2% 
vs. 40.5%; p < 0.0001) and obesity (35.2% vs. 21.6%; p = 0.04), while 
patients > 45 years showed a greater propensity to present systemic 
arterial hypertension (69.7% vs. 40.7%; p < 0.0001), diabetes mellitus 
(33.3% vs. 14.8%; p = 0.005), dyslipidemia (34.0% vs. 13.0%; p = 0.002), 
and  previous myocardial infarction (9.4% vs. 0.0%; p = 0.02; Table 1).
Anterior wall infarction was more frequent (50.9%), with stenting 
in 90.4% of procedures, predominantly with bare-metal stents 
(98.6%); manual aspiration thrombectomy, radial access, and glyco-
protein IIb/IIIa inhibitors were used in 57.5%, 94.3%, and 47.0% of the 
cases, respectively, with no difference between groups (Table 2). Pri-
mary PCI in young patients was associated with the use of fewer gui-
de catheters (1.1 vs. 1.3, p = 0.02), shorter fluoroscopy time (10.0 ± 4.4 
vs. 15.3 ± 23.1 min; p = 0.09), and a higher percentage of direct sten-
ting (61.1% vs. 47.1%; p = 0.06). 
The overall angiographic success rate was high (92.2%); and young 
patients exhibited good in-hospital evolution, with reduced mortality 
(1.9% vs. 6.7%; p = 0.23) and reinfarction (1.9% vs. 1.8%; p > 0.99) rates and 
no occurrence of stroke, stent thrombosis, and major bleeding (Table 3).
Discussion
Although hospitalizations for acute myocardial infarction cur-
rently present a downward trend, this is not observed in young pa-
tients.12 Consequently, the statistics show a decline in the mean age 
of STEMI cases, as well as in mortality rate, and these findings are 
justified by the prognostic impact of advanced age in this high-risk 
scenario, representing one of its main determinants of morbidity 
and mortality.13 
Table 1
Basal clinical and demographic characteristics.
Variable General 
(n = 489)
Age ≤ 45 years 
(n = 54)
Age > 45 years 
(n = 435)
p-value
Male gender, n (%) 338 (69.1) 34 (63.0) 304 (69.9) 0.35
Age, years 61.6 ± 12.4 40.7 ± 3.7 64.2 ± 10.5 < 0.0001
Body mass index, kg/m2 27.0 ± 4.9 28.5 ± 5.3 26.8 ± 4.8 0.02
Obesity, n (%) 113 (23.1) 19 (35.2) 94 (21.6) 0.04
Systemic arterial hypertension, n (%) 325 (66.5) 22 (40.7) 303 (69.7) < 0.0001
Diabetes mellitus, n (%) 153 (31.3) 8 (14.8) 145 (33.3) 0.005
Insulin user 23 (15.0) 2 (25.0) 21 (14.5) 0.34
Dyslipidemia, n (%) 155 (31.7) 7 (13.0) 148 (34.0) 0.002
Current smoker, n (%) 215 (44.0) 39 (72.2) 176 (40.5) < 0.0001
Positive family history of CAD, n (%) 91 (18.6) 15 (27.8) 76 (17.5) 0.09
Previous myocardial infarction, n (%) 41 (8.4) 0 (0.0) 41 (9.4) 0.02
Prior PCI, n (%) 42 (8.6) 1 (1.9) 41 (9.4) 0.07
Prior CABG, n (%) 7 (1.4) 0 (0.0) 7 (1.6) > 0.99
Stroke, n (%) 17 (3.5) 0 (0.0) 17 (3.9) 0.24
Chronic renal failure, n (%) 15 (3.1) 0 (0.0) 15 (3.4) 0.39
CAD: coronary artery disease; PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft. 
Table 2
Angiographic and procedural characteristics.
Variable General 
(n = 489)
Age ≤ 45 years 
(n = 54)
Age > 45 years 
(n = 435)
p-value
De novo injury, n (%) 483 (98.8) 53 (98.1) 430 (98.9) 0.51
In-stent restenosis, n (%) 6 (1.2) 1 (1.9) 5 (1.1) 0.51
Location, n (%) 0.56
Anterior 249 (50.9) 30 (55.6) 219 (50.3)
Inferior 240 (49.1) 24 (44.4) 216 (49.7)
Duration of the procedure, minutes 41.6 ± 19.1 38.1 ± 14.6 42.0 ± 19.6 0.16
Fluoroscopy time, minutes 14.5 ± 19.0 10.0 ± 4.4 15.3 ± 23.1 0.09
Door-to-balloon time, minutes 64.9 ± 34.9 63.6 ± 46.5 65.3 ± 29.9 0.71
Manual aspiration thrombectomy, n (%) 281 (57.5) 34 (63.0) 247 (56.8) 0.47
Direct stent implantation, n (%) 238 (58.9) 33 (61.1) 205 (47.1) 0.06
Post-dilation, n (%) 278 (56.9) 27 (50.0) 251 (57.7) 0.31
Access route, n (%) 0.16
Radial 461 (94.3) 54 (100.0) 407 (93.6)
Femoral 23 (4.7) 0 (0.0) 23 (5.3)
Ulnar 5 (1.0) 0 (0.0) 5 (1.1)
Culprit lesion, n (%) 0.51
Left anterior descending artery 247 (50.6) 30 (55.6) 217 (49.9)
Right coronary artery 185 (37.8) 21 (38.9) 164 (37.7)
Left circumflex artery 55 (11.2) 3 (5.5) 52 (12.0)
Left main coronary artery 2 (0.4) 0 (0.0) 2 (0.4)
Glycoprotein IIb/IIIa inhibitor, n (%) 230 (47.0) 31 (57.4) 199 (45.7) 0.11
Number of catheters 1.3 ± 0.6 1.1 ± 0.4 1.3 ± 0.6 0.018
Diameter of the catheter, n (%) > 0.99
5 F 1 (0.2) 0 (0.0) 1 (0.2)
6 F 487 (99.6) 54 (100.0) 433 (99.6)
7 F 1 (0.2) 0 (0.0) 1 (0.2)
PCI type, n (%) 0.81
Balloon angioplasty 47 (9.6) 4 (7.4) 43 (9.9)
Stenting 442 (90.4) 50 (92.6) 392 (90.1)
Number of stents 1.1 ± 0.5 1.1 ± 0.6 1.1 ± 0.5 > 0.99
Stent type, n (%) > 0.99
Drug-eluting stent 6 (1.4) 2 (4.0) 4 (1.0)
Bare-metal stent 436 (98.6) 48 (96.0) 388 (99.0)
Intra-aortic balloon, n (%) 2 (0.4) 0 (0.0) 2 (0.5) > 0.99
PCI: percutaneous coronary intervention.
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Table 3
In-hospital efficacy and safety outcomes.
Variable General 
(n = 489)
Age ≤ 45 years 
(n = 54)
Age > 45 years 
(n = 435)
p-value
Angiographic success, n (%) 451 (92.2) 51 (94.4) 400 (92.0) 0.79
MACE, n (%) 42 (8.6) 2 (3.7) 40 (9.2) 0.30
Death, n (%) 30 (6.1) 1 (1.9) 29 (6.7) 0.23
Reinfarction, n (%) 9 (1.8) 1 (1.9) 8 (1.8) > 0.99
Stroke, n (%) 1 (0.2) 0 (0.0) 1 (0.2) > 0.99
In-hospital stent thrombosis, n (%) 9 (1.8) 0 (0.0) 9 (2.1) 0.61
Acute 2 (0.4) 0 (0.0) 2 (0.5)
Subacute 7 (1.4) 0 (0.0) 7 (1.6)
Major bleeding, n (%) 4 (0.8) 0 (0.0) 4 (0.9) > 0.99
MACE: major adverse cardiac events (death, reinfarction, stroke, stent thrombosis, or major bleeding).
Data from registries such as FAST-MI (French Registry of Acute 
ST-Elevation or non-ST-elevation Myocardial Infarction) still 
show increased prevalence of smoking (from 32.0% to 40.9%) and 
obesity (from 14.3% to 20.1%) in the population of myocardial in-
farction patients over the past 15 years.2 In the USA, among young 
individuals aged 18-44 years, 22.9% of men and 16.6% of women 
are smokers, and 69% of the general population is classified as 
obese or overweight.1 
In assessing the population of young patients with an acute myo-
cardial infarction diagnosis, the percentage of smokers can reach up 
to 74%, as in the CRAGS (Coronary Artery Disease in Young Adults) 
study.14 It is known that smoking contributes negatively in the regu-
lation cascades engaged in preventing coronary occlusion, besides 
promoting changes in tissue plasminogen activator response to bra-
dykinin. Furthermore, the hypercoagulability state and endothelial 
dysfunction present in smokers predispose to the formation of intra-
coronary thrombi.15
In the present study, patients aged ≤ 45 years represented 11% of 
all STEMI cases (37% female), with high prevalence of modifiable 
risk factors such as obesity (35.2%) and smoking (72.2 %), and lower 
percentages of hypertension, dyslipidemia, diabetes mellitus, and 
previous  myocardial infarction. The characteristics of procedures 
– for instance, a lower mean number of catheters used, shorter flu-
oroscopy time, and higher percentage of direct stent implantation 
– suggest less angiographic complexity in this subgroup, as well as 
a low rate of major adverse cardiac events during hospitalization, 
exemplif ied by mortality rates of 1.9% vs. 6.7% in patients 
> 45 years. Similar findings were reported by the London Chest 
Hospital, a reference center for chest pain, which, from 2004 to 
2012, registered 3,618 primary PCIs. Patients aged ≤ 45 years cons-
tituted 10.1% of the sample, and smoking had a prevalence of 62.7%, 
with a 30-day mortality of 1.6%.16
Together, these data reflect the importance of instituting health 
policies that address young people and target primary or secondary 
prevention, with emphasis on changes in lifestyle, particularly 
smoking cessation, regular physical activity, and a balanced diet to 
maintain proper weight. These are low-cost actions with great po-
tential for reducing the incidence of new cases of myocardial infarc-
tion in this population.
Study limitations
This analysis had the following limitations: its observational and 
unicentric nature, the limited sample size, lack of long-term clinical 
follow-up, as well as non-performance of routine diagnostic tests for 
illicit drugs such as cocaine, a known promoter of coronary spasm 
and hypercoagulability in an environment of sympathetic activity 
exacerbation, which represents a common cause of acute coronary 
syndrome in young people.
Conclusions
Patients aged ≤ 45 years represented approximately 10% of cases 
of ST-segment elevation acute myocardial infarction, showed high 
prevalence of modifiable risk factors, especially smoking, favorable 
in-hospital clinical outcome after primary percutaneous coronary 
intervention, and less technical complexity when compared to pa-
tients > 45 years. Health policies addressing changes in lifestyle are 
low-cost actions, with potential impact on reducing future events in 
this population.
Funding source
None declared.
Conflicts of interest
The authors declare no conflicts of interest.
References
1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al.; 
American Heart Association Statistics Committee and Stroke Statistics 
Subcommittee. Heart disease and stroke statistics — 2015 update: a report from 
the American Heart Association. Circulation. 2015;131(4):e29-e322.
2. Puymirat E, Simon T, Steg PG, Schiele F, Guéret P, Blanchard D, et al.; USIK USIC 
2000 Investigators; FAST MI Investigators. Association of changes in clinical 
characteristics and management with improvement in survival among patients 
with ST-elevation myocardial infarction. JAMA. 2012;308(10):998-1006.
3. Matte BS, Bergoli LCC, Balvedi JA, Zago AC. Perfil da intervenção coronária 
percutânea no infarto agudo do miocárdio com supradesnivelamento do 
segmento ST no Brasil de 2006 a 2010 – Registro CENIC. Rev Bras Cardiol Invasiva. 
2011;19(2):131-7.
4. Bienert IRC, Ribeiro EE, Kajita LJ, Perin MA, Campos CAH, Trentin F, et al. 
Prognóstico tardio em jovens com coronariopatia estável: evolução em 10 anos 
após inter venç ão coronár ia perc ut ânea . Rev Bras C ardiol Invasiva . 
2012;20(4):161-5.
5. Cantarelli MJC, Castello Jr. HJ, Gonçalves R, Gioppato S, Navarro E, Guimarães JBF, 
et al. Intervenção coronária percutânea em jovens. Rev Bras Cardiol Invasiva 
2014;22(4):355-8.
6. Choudhury L, Marsh JD. Myocardial infarction in young patients. Am J Med. 
1999;107(3):254-61.
7. Hoit BD, Gilpin EA, Henning H, Maisel AA, Dittrich H, Carlisle J, et al. Myocardial 
infarction in young patients: an analysis by age subsets. Circulation. 
1986;74(4):712-21.
8. Conti RAS, Solimene MC, Luz PL , Benjó AL, Lemos Neto PA, Ramires JAF. 
Comparação entre homens e mulheres jovens com infarto agudo do miocárdio. 
Arq Bras Cardiol. 202;79(5):510-7.
9. Task Force on the management of ST-segment elevation acute myocardial 
infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, 
Badano LP, Blömstrom-Lundqvist C, et al. ESC Guidelines for the management of 
acute myocardial infarction in patients presenting with ST-segment elevation. 
The Task Force on the management of St-segment elevation acute myocardial 
infarct ion of the European Societ y of Cardiolog y (ESC). Eur Hear t J . 
2012;33(20):2569-619.
 P. de Andrade et al. / Rev Bras Cardiol Invasiva. 2015;23(2):91-95 95
10. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr., Chung MK, de Lemos JA, et al.; 
American College of Cardiology Foundation/American Heart Association Task 
Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of 
ST-elevation myocardial infarction: a report of the American College of 
Cardiology Foundation/American Heart Association Task Force on Practice 
Guidelines. Circulation. 2013;127(4):e362-e425.
11. Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized 
bleeding definitions for cardiovascular clinical trials: a consensus report from 
the Bleeding Academic Research Consortium. Circulation. 2011;123(23):2736-47.
12. Gupta A, Wang Y, Spertus JA, Geda M, Lorenze N, Nkonde-Price C, et al. Trends in 
acute myocardial infarction in young patients and differences by sex and race, 
2001 to 2010. J Am Coll Cardiol. 2014;64(4):337-45.
13. Pedersen F, Butrymovich V, Kelbæk H, Wachtell K, Helqvist H, Kastrup J, et al. 
Short and long-term cause of death in patients treated with primary PCI for 
STEMI. J Am Coll Cardiol. 2014;64(20):2101-8.
14. Lautamaki A, Airaksinen KEJ, Kiviniemi T, Vinco G, Ribichini F, Gunn J, et al. 
Prognosis and disease progression in patients under 50 years old undergoing PCI: 
The CRAGS (Coronary aRtery diseAse in younG adultS) study. Atherosclerosis. 
2014;235(2):483-7.
15. Davidson L, Wilcox J, Kim D, Benton S, Fredi J, Vaughan D. Clinical features of 
precocious acute coronary syndrome. Am J Med. 2014;127(2):140-4.
16. Rathod KS, Jones DA, Gallagher S, Rathod VS, Weerackody R, Jain AK, et al. 
Atypical risk factor profile and excellent long-term outcomes of young patients 
treated with primary percutaneous Coronary intervention for ST-elevation 
myocardial infarct ion. Eur Hear t J Acute Cardiovasc Care. 2015; pii: 
2048872614567453. Epub ahead of print.
